Transcatheter vs surgical valve replacement for severe bicuspid aortic stenosis
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years of age or older.
- You have severe aortic stenosis (a narrowed heart valve) and your heart team agrees a tissue valve is a good option for you.
- You've had a CT scan that shows your aortic valve is bicuspid (two flaps instead of three) and the scan is available for review.
- You have not had a heart procedure or stroke in the last 30 to 90 days, depending on the type.
- You do not have serious health problems like severe kidney disease, very low blood counts, or severe lung disease.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for severe aortic stenosis in people with a bicuspid aortic valve: transcatheter aortic valve replacement (TAVR, a less invasive procedure) and surgical aortic valve replacement (SAVR, open-heart surgery). The goal is to see which approach works better for this specific condition.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This trial compares two ways to replace a narrowed aortic heart valve in patients aged 65 to 75. It aims to find which approach—surgical valve replacement or a catheter-based procedure—works better for people in this age group.
This study checks whether an “investigational” transcatheter aortic valve is safe and works well for people with severe, calcified aortic stenosis (a stiff, narrowed heart valve). It may help improve valve function and symptoms, but you must meet specific heart, scan, and health-status requirements.
This study looks at how safe and effective an emergency heart valve replacement is for people with severe aortic stenosis who are in critical condition. It may help if you have severe symptoms like shock or unstable chest pain that need urgent treatment.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
Hear when a new Bicuspid Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.